VcMMAE

VcMMAE (mc-vc-PAB-MMAE) is a drug-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the lysosomally cleavable dipeptide, valine-citrulline (vc).
Supplier CD BioSciences
Product # CIA-11382
Pricing 50 mg;500 mg;1 g;Customized Size, Inquire
Feedback